Keros Therapeutics

Forecast & Rating7 analysts currently cover Keros Therapeutics, with about 42.9% giving a positive rating — meaning they expect the stock to rise. The average price target is $21.83, about 116.8% upside from the current price of $10.07. Price targets range from $16.00 to $30.00 — a wide spread, showing clear disagreement over just how much Keros Therapeutics can rise. For you, this means institutional views on Keros Therapeutics are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Jun 3, 2026; for reference only and not investment advice.